An intact HDM2 RING-finger domain is required for nuclear exclusion of p53

Nature Cell Biology

Volumn 2, Issue 9, 2000, Pages 563-568

  Boyd, Scott D ^a,b   Tsai, Kenneth Y ^a,b   Jacks, Tyler ^a  

^a MASSACHUSETTS INSTITUTE OF TECHNOLOGY   (United States)

^b HARVARD MIT DIVISION OF HEALTH SCIENCES AND TECHNOLOGY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PROTEIN P53;

ANIMAL CELL; ARTICLE; CELLULAR DISTRIBUTION; DNA DAMAGE; MOLECULAR INTERACTION; NONHUMAN; PRIORITY JOURNAL; PROTEIN LOCALIZATION; PROTEIN PROTEIN INTERACTION;

3T3 CELLS; ACTIVE TRANSPORT, CELL NUCLEUS; ANIMAL; CELL NUCLEUS; CYTOPLASM; HUMAN; MICE; MUTAGENESIS; PROTEIN P53; PROTEIN STRUCTURE, TERTIARY; PROTO-ONCOGENE PROTEINS; RECOMBINANT FUSION PROTEINS; SUPPORT, NON-U.S. GOV'T; TUMOR CELLS, CULTURED; UBIQUITINS; ZINC FINGERS;

EID: 0034282102     PISSN: 14657392     EISSN: None     Source Type: Journal    
DOI: 10.1038/35023500     Document Type: Article

References (33)

1. Levine, A. J. p53, the cellular gatekeeper for growth and division. Cell 88, 323-331 (1997).
2. Lin, J., Chen, J., Elenbaas, B. & Levine, A. J. Several hydrophobic amino acids in the p53 amino-terminal domain are required for transcriptional activation, binding to mdm-2 and the adenovirus 5E1B 55-kD protein. Genes Dev. 8, 1235-1246 (1994).
3. Honda, R., Tanaka, H. & Yasuda, H. Oncoprotein MDM2 is a ubiquitin ligase for tumor suppressor p53. FEBS Lett. 420, 25-27 (1997).
4. Roth, J., Dobbelstein, M., Freedman, D. A., Shenk, T. & Levine, A. J. Nucleo-cytoplasmic shuttling of the hdm2 oncoprotein regulates the levels of the p53 protein via a pathway used by the human immunodeficiency virus rev protein. EMBO J. 17, 554-564 (1998).
5. Tao, W. & Levine, A. J. Nucleocytoplasmic shuttling of oncoprotein Hdm2 is required for Hdm2-mediated degradation of p53. Proc. Natl Acad. Sci. USA 96, 3077-3080 (1999).
6. Fornerod, M., Ohno, M., Yoshida, M. & Mattaj, I. W. CRM1 is an export receptor for leucine-rich nuclear export signals. Cell 90, 1051-1060 (1997).
7. Fukuda, M. et al. CRM1 is responsible for intracellular transport mediated by the nuclear export signal. Nature 390, 308-311 (1997).
8. Ossareh-Nazari, B., Bachelerie, F. & Dargemont, C. Evidence for a role of CRM1 in signal-mediated nuclear protein export. Science 278, 141-144 (1997).
9. Freedman, D. A. & Levine, A. J. Nuclear export is required for degradation of endogenous p53 by MDM2 and human papillomavirus E6. Mol. Cell Biol. 18, 7288-7293 (1998).
10. Middeler, G. et al. The tumor suppressor p53 is subject to both nuclear import and export, and both are fast, energy-dependent and lectin-inhibited. Oncogene 14, 1407-1417 (1997).
11. Stommel, J. M. et al. A leucine-rich nuclear export signal in the p53 tetramerization domain: regulation of subcellular localization and p53 activity by NES masking. EMBO J. 18, 1660-1672 (1999).
12. Haupt, Y., Maya, R., Kazaz, A. & Oren, M. Mdm2 promotes the rapid degradation of p53. Nature 387, 296-299 (1997).
13. Kubbutat, M. H., Ludwig, R. L., Ashcroft, M. & Vousden, K. H. Regulation of Mdm2-directed degradation by the C terminus of p53. Mol. Cell Biol. 18, 5690-5698 (1998).
14. Marston, N. J., Jenkins, J. R. & Vousden, K. H. Oligomerisation of full length p53 contributes to the interaction with mdm2 but not HPV E6. Oncogene 10, 1709-1715 (1995).
15. Elenbaas, B., Dobbelstein, M., Roth, J., Shenk, T. & Levine, A. J. The MDM2 oncoprotein binds specifically to RNA through its RING finger domain. Mol. Med. 2, 439-451 (1996).
16. Tanimura, S. et al. MDM2 Interacts with MDMX through their RING finger domains. FEBS Lett. 447, 5-9 (1999).
17. Fang, S., Jensen, J. P., Ludwig, R. L., Vousden, K. H. & Weissman, A. M. Mdm2 is a RING finger-dependent ubiquitin protein ligase for itself and p53. J. Biol. Chem. 275, 8945-8951 (2000).
18. Waldman, T., Kinzler, K. W. & Vogelstein, B. p21 is necessary for the p53-mediated G1 arrest in human cancer cells. Cancer Res. 55, 5187-5190 (1995).
19. Chowdary, D. R., Dermody, J. J., Jha, K. K. & Ozer, H. L. Accumulation of p53 in a mutant cell line defective in the ubiquitin pathway. Mol. Cell Biol. 14, 1997-2003 (1994).
20. Marechal, V., Elenbaas, B., Piette, J., Nicolas, J. C. & Levine, A. J. The ribosomal L5 protein is associated with mdm-2 and mdm-2-p53 complexes. Mol. Cell Biol. 14, 7414-7420 (1994).
21. Moy, T. & Silver, P. A. Nuclear export of the small ribosomal subunit requires the Ran-GTPase cycle and certain nucleoporins. Genes Dev. 13, 2118-2133 (1999).
22. Brooks, P. et al. Subcellular localization of proteasomes and their regulatory complexes in mammalian cells. Biochem. J. 346, 155-161 (2000).
23. Kamura, T. et al. Rbxl, a component of the VHL tumor suppressor complex and SCF ubiquitin ligase. Science 284, 657-661 (1999).
24. grr and Rbxl. Science 284, 662-665 (1999).
25. Zaika, A., Marchenko, N. & Moll, U. M. Cytoplasmically 'sequestered' wild type p53 protein is resistant to Mdm2-mediated degradation. J. Biol. Chem. 274, 27474-27480 (1999).
26. Terrell, J., Shih, S., Dunn, R. & Hicke, L. A function for monoubiquitination in the internalization of a G protein-coupled receptor. Mol. Cell 1, 193-202 (1998).
27. Hicke, L. Ubiquitin-dependent internalization and down-regulation of plasma membrane proteins. FASEB J. 11, 1215-1226 (1997).
28. Gostissa, M. et al. Activation of p53 by conjugation to the ubiquitin-like protein SUMO-1. EMBO J. 18, 6462-6471 (1999).
29. Rodriguez, M. S. et al. SUMO-1 modification activates the transcriptional response of p53. EMBO J. 18, 6455-6461 (1999).
30. Lohrum, M. A. E., Ashcroft, M., Kubbutat, M. H. G. & Vousden, K. H. Identification of a cryptic nucleolar-localization signal in MDM2. Nature Cell Biol. 2, 179-181 (2000).
31. Weber, J. D., Taylor, L. J., Roussel, M. F., Sherr, C. J. & Bar-Sagi, D. Nucleolar Arf sequesters Mdm2 and activates p53. Nature Cell Biol. 1, 20-26 (1999).
32. Zhang, Y. & Xiong, Y. Mutations in human ARF exon 2 disrupt its nucleolar localization and impair its ability to block nuclear export of MDM2 and p53. Mol. Cell 3, 579-591 (1999).
33. Honda, R. & Yasuda, H. Association of p19ARF with Mdm2 inhibits ubiquitin ligase activity of Mdm2 for tumor suppressor p53. EMBO J. 18, 22-27 (1999).